Vicore Pharma Holding AB
VCRE | NASDAQ
$9.62
-$0.18 (-1.84%)
Nov 2, 2026, 11:59 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
Net Income | -452.39M | -194.19M | -321.51M | -290.73M | -32.78M |
Depreciation & Amortization | n/a | 2.24M | 3.42M | 3.61M | 397.75K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | -172.79K |
Other Working Capital | 43.89M | 33.77M | -6.36M | -19.34M | n/a |
Other Non-Cash Items | 35.84M | 28.84M | 79.15M | 8.13M | -231.23M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 40.81M | -1.84M | -10.65M | -20.94M | -37.59K |
Operating Cash Flow | -375.74M | -164.95M | -249.58M | -299.92M | -263.82M |
Capital Expenditures | n/a | n/a | n/a | -3M | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -983.95M | -64.81M | -199.04M | n/a | -76.61M |
Sales Maturities Of Investments | 383.45M | 213.85M | 54.58M | 77M | 69.64M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -600.51M | 149.04M | -144.46M | 74M | -6.96M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -24.55M | -48.08M | -29.55M | -12.96M | -237.78K |
Financial Cash Flow | 430.54M | 834.06M | 470.86M | 187.04M | 316.56M |
Net Cash Flow | -577.85M | 822.38M | 76.82M | -37.4M | 2.3M |
Free Cash Flow | -375.74M | -164.95M | -249.58M | -302.92M | -263.82M |
Adj. Free Cash Flow | -375.74M | -164.95M | -249.58M | -302.92M | -263.65M |
Maintenance CapEx | n/a | n/a | n/a | -3M | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -375.74M | -164.95M | -249.58M | -302.92M | -263.82M |
Add to Watchlist
Select watchlists to add or remove VCRE